Prior to joining Accumetrics, Mr Dippel was vice president of operations at Barrx Medical. Mr Dippel holds a BS in mechanical engineering from the California State Polytechnic University,
HemaQuest has recently completed Phase I clinical trials of HQK-1001 in healthy subjects and plans to begin clinical studies of this compound in both sickle cell anemia and
The FDA approved Norditropin based on data from a 13-year clinical trial in children small for gestational age (SGA). The study showed that 63% of children who reached
The decision was made following a review of results by the company’s board of directors from the company’s ongoing UK Phase I and Phase II combination Reolysin and
Mylan and UCB Societe Anonyme and UCB Pharma have previously entered into an agreement to settle pending litigation relating to levetiracetam tablets. Pursuant to the settlement, Mylan was
The partnership with Therapure builds upon BioVectra’s expertise in the production of modified biologic molecules using a proprietary MPEG technology. Therapure, from its 130,000 square feet facilities in
Scheduled for completion by the end of 2009, the national reference laboratory (NRL) will be the first of its kind in the region to provide a centralized solution
Sarah Cannon Research Institute (SCRI) selected OmniComm for several key reasons, including TrialMaster’s functionality. However, the deciding factor was OmniComm’s responsiveness and the level of service that the
With both companies sharing a common goal of educating the health-conscious individual about being proactive with medical choices in order to live a longer, better life, the alliance
SurModics paid $3 million in cash at closing and may pay up to an additional $6 million in cash upon the successful achievement of certain milestones. The acquisition
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.